Actually management has already gotten on top of this. So due to the DEA we used different suppliers, this resulted in a difference of results between the two groups. When looking at the Aus group the data is presented like x. We conducted a root cause analysis and identified that it was the supply. We then mitigated a supply risk by locking in an agreement as this will be needed for phase 3...
Looking forward to the FDA meeting to help advise us from here.
Actually management has already gotten on top of this. So due to...
-
- There are more pages in this discussion • 130 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
0.015(4.23%) |
Mkt cap ! $669.7M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 37.5¢ | 35.5¢ | $1.465M | 4.001M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 186321 | 36.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.5¢ | 561591 | 7 |
View Market Depth
| Last trade - 16.10pm 14/08/2024 (20 minute delay) ? |
| BOT (ASX) Chart |